Peregrine Asset Advisers’s Astera Labs ALAB Stock Holding History

Peregrine Asset Advisers’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-33,905	Closed	-$2.52M	–	191
2024 Q1	$2.52M	Buy	+33,905	New	+$2.51M	1%	26

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Intel Corp Santa Clara, California $470M AUM 21.74% 1-Year Est. Return

Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

SPPAM

Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return

Peregrine Asset Advisers's ALAB Position: Q2 2024 in Review

Peregrine Asset Advisers sold out of Astera Labs (ALAB) in Q2 2024, closing a stake of 33,905 shares — an estimated $2.52M sold.

Peregrine Asset Advisers first reported a position in ALAB in Q1 2024 and held it in 1 quarter. The position peaked at $2.52M in Q1 2024. 146 funds tracked by Wall St. Rank hold ALAB as of Q2 2024.

Peregrine Asset Advisers reported no remaining Astera Labs position as of Q2 2024 after selling out during the quarter.
Peregrine Asset Advisers sold 33,905 Astera Labs shares in Q2 2024, an estimated $2.52M.
Peregrine Asset Advisers first reported a position in Astera Labs in Q1 2024 and held it in 1 quarter.
Peregrine Asset Advisers's Astera Labs position peaked at $2.52M in Q1 2024.
146 funds tracked by Wall St. Rank held Astera Labs as of Q2 2024.

Based on Peregrine Asset Advisers's 13F filing for Q2 2024, filed 9 Aug 2024.